Table 2. Kruskal-Wallace test (p < 0.05) with post-hoc pairwise analysis of HPC and CTX ERK 1/2 phosphorylation following NGF treatment with and without PLX4032.

Factor	n	Average Rank	Different (p < 0.05) from factor n
1) CTX_DMSO	3	6.33	(4)(5)(6)
(2) CTX_NGF	3	3.33	(4)(5)(6)
(3) CTX_PLX NGF	3	5.33	(4)(5)(6)
(4) HPC_DMSO	3	12	(1)(2)(3)(6)
(5) HPC_NGF	3	13	(1)(2)(3)
(6) HPC_PLX_NGF	3	17	(1)(2)(3)(4)